Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.01 | uM | 9 | 312.50 | 153.73 | 159.00 | 312.00 | 0.5096 | 0.0336 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 410.00 | 312.00 | 1.3141 | 1.6134 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 472.00 | 312.00 | 1.5128 | 1.9998 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 312.50 | 153.73 | 115.00 | 312.00 | 0.3686 | -0.2474 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 400.00 | 312.00 | 1.2821 | 1.5509 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 365.00 | 312.00 | 1.1699 | 1.3321 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 302.00 | 312.00 | 0.9680 | 0.9372 |
| BT-20 | Lapatinib | 1 | uM | 9 | 312.50 | 153.73 | 247.00 | 312.00 | 0.7917 | 0.5910 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 296.00 | 312.00 | 0.9487 | 0.8995 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 605.00 | 817.25 | 0.7403 | 0.6012 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 625.00 | 320.09 | 800.00 | 817.25 | 0.9789 | 0.9687 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 644.00 | 817.25 | 0.7880 | 0.6769 |
| BT-20 | Linsitinib | 10 | uM | 9 | 625.00 | 320.09 | 591.00 | 817.25 | 0.7232 | 0.5738 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 832.00 | 817.25 | 1.0180 | 1.0266 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 843.00 | 817.25 | 1.0315 | 1.0464 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 843.00 | 817.25 | 1.0315 | 1.0464 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 320.09 | 1007.00 | 817.25 | 1.2322 | 1.3339 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 955.00 | 817.25 | 1.1686 | 1.2442 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 625.00 | 320.09 | 1188.00 | 817.25 | 1.4537 | 1.6373 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 907.00 | 817.25 | 1.1098 | 1.1602 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 946.00 | 817.25 | 1.1575 | 1.2285 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 320.09 | 871.00 | 817.25 | 1.0658 | 1.0965 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 892.00 | 817.25 | 1.0915 | 1.1337 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 320.09 | 1017.00 | 817.25 | 1.2444 | 1.3510 |
| BT-20 | Erlotinib | 10 | uM | 9 | 625.00 | 320.09 | 610.00 | 817.25 | 0.7464 | 0.6110 |